Urinary [TIMP-2] × [IGFBP-7] for predicting acute kidney injury in patients undergoing orthotopic liver transplantation
Open Access
- 17 July 2019
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 20 (1) , 1-7
Abstract
The product of the concentrations of urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor binding protein-7 (urinary [TIMP-2] × [IGFBP-7]) has been suggested as biomarker for early detection of acute kidney injury (AKI) in various clinical settings. However, the performance of urinary [TIMP-2] × [IGFBP-7] to predict AKI has never been assessed in patients undergoing orthotopic liver transplantation (OLT). Thus, the aim of this study was to assess the early predictive value of urinary [TIMP-2] × [IGFBP-7] for the development of AKI after OLT. In this observational study, urinary [TIMP-2] × [IGFBP-7] was measured in samples from adult OLT patients. AKI was diagnosed and classified according to KDIGO criteria. Areas under the receiver operating curves (AUC) were calculated to assess predictive values of urinary [TIMP-2] × [IGFBP-7] for the development of AKI. Forty patients (mean age 55 ± 8 years) were included. Twenty-eight patients (70%) developed AKI stage 1, 2, or 3 within 48 h after OLT. Urinary [TIMP-2] × [IGFBP-7] was not predictive for AKI at the end of OLT (AUC: 0.54, CI [0.32–0.75], P = 0.72), at day 1 (AUC: 0.60, CI [0.41–0.79], P = 0.31), or day 2 after OLT (AUC: 0.63, CI [0.46–0.8], P = 0.18). Based on our results, routine clinical use of urinary [TIMP-2] × [IGFBP-7] cannot be recommended for risk assessment of AKI in patients undergoing OLT.Keywords
Funding Information
- Pfizer Medical Austria (na)
This publication has 31 references indexed in Scilit:
- Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteriaTransplant International, 2013
- Discovery and validation of cell cycle arrest biomarkers in human acute kidney injuryCritical Care, 2013
- Imperfect Gold Standards for Kidney Injury Biomarker EvaluationJournal of the American Society of Nephrology, 2012
- Rifle Criteria for Acute Kidney Dysfunction Following Liver Transplantation: Incidence and Risk FactorsTransplantation Proceedings, 2010
- Acute Kidney Injury During Liver Transplantation as Determined by Neutrophil Gelatinase-Associated LipocalinLiver Transplantation, 2009
- Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2009
- Acute kidney injury following liver transplantation: Definition and outcomeLiver Transplantation, 2009
- Risk factors of acute renal failure after liver transplantationKidney International, 2006
- Defining acute renal failure: physiological principlesIntensive Care Medicine, 2003
- Impact of acute renal failure on mortality in end-stage liver disease with or without transplantationKidney International, 1998